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Clinical observation has proposed the linkage between the occurrence of obesity 
and slow weight loss with daily exposure to common food additives such as sodium 
benzoate. However, well-controlled laboratory experiments on this topic have been 
lacking; the dose-response relationship of sodium benzoate and obesity occurrence 
and/or slow weight loss has not been established; the potential mechanism of such 
linkage has not been explored. The insulin-signaling and fatty acid synthesis pathways 
in the model organism Caenorhabditis elegans (C. elegans) are highly conserved with 
higher organism including humans and thereby has been widely utilized to study obesity 
and aging related mechanisms. Scientific literature links the insulin pathway of C. 
elegans to growth, development, longevity, behavior, and metabolism in the 
organism. C. elegans is also a perfect model for exploring the genetics of fat storage. 
Thereby, C. elegans was used as a model organism to study the effects of sodium 
benzoate exposure on fat storage and on the gene expression of major players in 
insulin signaling and fatty acid synthesis pathway, as well as, key nuclear hormone 
receptor genes. This study demonstrated that C. elegans growth was greatly affected 
over time with exposure to sodium benzoate. This study could not provide a clear 
conclusion about the effects of sodium benzoate on fat deposition. Sodium benzoate 
exposure also led to the down-regulation of one nuclear hormone receptor gene, and 
two genes involved in fatty acid synthesis. After 72 hours of exposure, all treatment 
groups were larger than the control group, with the highest treatment causing 
significantly more growth. After 72 hours of exposure all treatment groups showed 
higher fluorescence values than the control group, with the lowest treatment group 
demonstrating significantly higher fluorescence levels than the control group. Three 
genes of interest were significantly downregulated after 24 hours exposure: nhr-50, fat-
1, and elo-5. These findings indicate that sodium benzoate exposure is significantly 
impacting the model organism C. elegans and could be significantly impacting humans 
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CHAPTER 1: INTRODUCTION 
Obesity is now recognized as a major problem around the world. According to the 
World Health Organization (WHO) in 2014 39% of the adults, aged 18 and over, were 
considered overweight, and 13% were considered obese [13]. In 2014 the WHO 
estimated that 67.3% of adults in the United States of America were considered 
overweight [8]. According to information published by the Centers for Disease Control 
and Prevention (CDC), based on information gathered from 2011-2014, it is estimated 
that 36.5% of adults in the United States of America, aged 20 and older, were considered 
obese [11].  Individuals are identified as being overweight if their body mass index (BMI) 
is ≥25, and they are identified as obese if their BMI is ≥30, and BMI is calculated as weight 
in kilograms divided by height in meters squared [10]. Obesity and being overweight are 
major risk factors for chronic diseases, such as: cancer, cardiovascular diseases, and 
diabetes [10]. A “chemical obesogen” hypothesis states that synthetic substances are 
contributing to the global epidemic of obesity, and intentional food additives are largely 
unstudied with regards to their effects on overall metabolic homeostasis [14]. Despite 
growing momentum regarding the chemical obesogen movement, evidence-based 
research to support the movement is greatly lacking, and tools and models from 
toxicology should be adopted [14]. A common food preservative that is greatly 
understudied at this time, regarding its potential effects on obesity, is sodium benzoate. 
Sodium benzoate is a colorless powder that is crystal-like in nature. It is commonly 
used as a food preservative, antiseptic, medicine, in tobacco, in pharmaceutical 
preparations, as an intermediate for manufacture of dyes, and as a rust and mildew 
inhibitor [15]. Sodium benzoate is used as a preservative in such foods as sauces, pickles, 
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cider, fruit juices, wine coolers, syrups and concentrates, mincemeat, margarine, egg 
powder, fish, bottled carbonated beverages, fruit preservatives, jams and jellies, and it is 
added directly to human food [15]. The demand of sodium benzoate had increased due 
to the popularity of diet drinks [15]. Currently, the US Food and Drug Administration limits 
the amount of sodium benzoate in food to 0.1% [3].  Sodium Benzoate is currently 
considered generally safe as a food additive [3]. However, there have been few recent 
studies examining its potential effects on obesity. The U.S. Environmental Protection 
Agency (EPA) does not currently have an established limit on sodium benzoate [2]. The 
EPA does have a published oral Reference Dose (RfD) for sodium benzoate, which is 
328 mg/day [2]. However, this RfD is “is based on the assumption that thresholds exist 
for certain toxic effects such as cellular necrosis” [2]. “In general, the RfD is an estimate 
(with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the 
human population (including sensitive subgroups) that is likely to be without an 
appreciable risk of deleterious effects during a lifetime” [2]. It should also be noted that 
the RfD value is based on a report published by the FDA in 1973 and the value has not 
been adjusted since 1988 [2]. Based on the lack of recent information regarding the 
potential effects of sodium benzoate on obesity, a model organism should be used to 
examine potential effects.  
Caenorhabditis elegans is considered a model organism for many reasons. It is an 
inexpensive, and time-efficient model because of its reduced lifespan. Traditionally 
rodents have been used in obesity studies, however, using the C. elegans will reduce the 
number of rodents and higher animals required, and this model can also serve as in 
important intermediate step before moving to higher organisms [16]. C. elegans is a small 
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nematode that does not require approval by Animal Care and Use Committees [16]. The 
Wild-type of this organism reaches adulthood within 38-46 hours after hatching, and the 
lifespan is approximately 21 days [6]. The worms have a generation time of 3 days and 
produce large numbers of offspring, with about 300 children per hermaphrodite [16]. Also, 
C. elegans was the first organism to have its genome completely sequenced, and more 
than 65% of human genes related to disease are conserved in the organism [16]. This 
organism is also a model for obesity studies due to its transparent body, and fat stores 
mainly within the hypodermal and intestinal cells that are easily stained with lipid affinity 
dyes, such as Nile Red [16]. These fluorescent dyes can easily be imaged through the 
transparent body of the worms [16]. Furthermore, C. elegans has highly conserved genes 
that regulate fat metabolism, and a major example is the sterol response element binding 
protein (SREBP) [9]. It also has conserved behavioral responses to satiety and starvation, 
which makes is a reasonable model system to show how feeding behavior is regulated 
by fat metabolism [9]. The effects of sodium benzoate on this model’s fat deposition were 
not previously known.  
Studies about sodium benzoate’s effect on obesity are minimal. One study 
published in the British Journal of Nutrition found that food additives, such as sodium 
benzoate, decrease the release of leptin from adipocytes in a state of chronic 
inflammation, which is associated with obesity [4]. A decrease in “leptin release during 
the consumption of nutrition-derived food additives would decrease the overall amount of 
circulating leptin and could thereby influence food intake and contribute to an obesogenic 
effect” [4]. Patients who are deficient in leptin cannot control feeding and as a result 
become severely obese, which indicates that a single gene mutation may be enough to 
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affect feeding behavior [9]. Leptin is released from adipose tissue and helps to signal the 
brain to reduce feeding, which indicates a communication between fat stores and the 
brain, and the communication between fat storage and the brain is likely conserved in 
other animals [9]. While C. elegans does not contain leptin, there is likely a ‘fat to brain’ 
communication that is evolutionarily conserved but has not been discovered [9]. C. 
elegans stores fat in the form of triglycerides in the intestine or hypodermis, and this 
storage method is common in many animals, including humans, and is considered to be 
an ancient way of storing fat before a designated fat tissue evolved [9]. The organism’s 
conserved genes that regulated fat metabolism, along with its conserved behavioral 
responses to starvation and satiety make it a good genetic model for studying how fat 
metabolism regulates feeding behavior [9]. Nuclear hormone receptors (NHRs) are a 
family of transcriptional factors, and many of these regulate metabolism in response to 
changes in nutritional inputs, and C. elegans contains about 7 times as many NHRs as 
mammals [9]. Some of the NHRs in C. elegans are involved in dauer formation [9]. The 
dauer is a dormant stage that the worms enter when environmental conditions are not 
favorable, and an example of this is starvation [9]. The dauer stage of the worms is tightly 
linked to an animal’s metabolic status because the worms enter that stage when it lacks 
nutrient signals like insulin [9]. Studies show that C. elegans NHRs serve conserved 
functions to regulate metabolism in response to changes in nutritional input, like those of 
animals [9]. One study showed that some NHRs helped to regulate fat storage and satiety 
in the worms [9]. The same study showed that a conserved fatty acid synthesis pathway 
regulates satiety in C. elegans [9]. Unlike Leptin the NHRs are conserved in both 
mammals and C. elegans and play critical roles in metabolism, often acting as receptors 
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for steroid or lipid hormones [9]. The study found that certain NHRs regulate feeding and 
fat storage which suggests that NHRs might mediate leptin-like response in invertebrate 
animals, however it should be noted that it is unknown whether NHRs regulate feeding 
behavior [9].  
Based on these previous findings, it was hypothesized that sodium benzoate 
exposure will induce increased fat storage in the model organism C. elegans at specific 
concentrations, due to an effect on NHRs that mediate leptin-like responses. These 
concentrations were 0.05% Sodium Benzoate, 0.1% Sodium Benzoate, and 0.5% Sodium 
Benzoate. Research in this area in extremely important due to a lack of current 
information on the subject. During this study, C. elegans will be exposed to various levels 
of sodium benzoate, their body fat stores will be stained using Nile Red dye, and the fat 
stores will be monitored over the course of their lifespan. Nile Red is a lipophilic dye that 
is derived from Nile Blue [12]. It becomes concentrated when in hydrophobic 
environments when used invitro or in cell lines [12]. When Nile Red is in a hydrophobic 
environment the dye undergoes an increase in yellow-gold fluorescence, which makes it 
a useful indicator of lipid droplets in cells [12]. Gene expression analysis was also 
performed on 30 genes of interest, including: key genes from the insulin signaling 
pathway, genes important for fatty acid synthesis, and genes that encode for NHRs 
previously shown to be upregulated during starvation and downregulated during refeeding 
[9]. The genes of interest and their known functions are displayed in Table 1 [5].  
 
Table 1. Genes of Interest. The table below shows genes of interest that encode for Nuclear 
Hormone Receptors, key players in the insulin signaling pathway, and genes involved in fatty acid 
synthesis. A brief description of functions of these known genes is provided. 
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Genes   Functions 
1. nhr-170 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety 
quiescence in some manner. 
2. nhr-206 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety 
quiescence in some manner and is an 
ortholog of human HNF4G (hepatocyte 
nuclear factor 4 gamma) and HNF4A 
(hepatocyte nuclear factor 4 alpha); nhr-
206 is involved in response to starvation. 
3. nhr-21 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety 
quiescence in some manner. 
4. nhr-64 (regulate fat storage and 
satiety quiescence) 
Encodes a conserved nuclear receptor 
that is a member of the NR2 subfamily of 
nuclear receptors that contains 
Drosophila and human HNF4 and a 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety 
quiescence in some manner. 
5. nhr-8 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety in 
some manner. 
6. nhr-50 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety in 
some manner. 
7. nhr-18 Nuclear hormone receptor gene encodes 
a member of the superfamily of nuclear 
receptors, which is one of the most 
abundant class of transcriptional 
regulators. 
8. nhr-120 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety in 
some manner. 
9. nhr-49  Nuclear hormone receptor that functions 
as a key regulator of fat metabolism and 
lifespan by regulating induction of beta-
oxidation genes upon food deprivation 
and activation of stearoyl-CoA desaturase 
in fed animals, respectively. 
10. nhr-162 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 




11. nhr-212 (regulate fat storage and 
satiety quiescence) 
Nuclear hormone receptor that was found 
to regulate fat storage and satiety in 
some manner. 
12. daf-2 Encodes a receptor tyrosine kinase that is 
the C. elegans insulin/IGF receptor 
ortholog and  DAF-2 signals through a 
conserved PI 3-kinase pathway to 
negatively regulate the activity of DAF-16, 
a Forkhead-related transcription factor, by 
inducing its phosphorylation and nuclear 
exclusion; in addition, DAF-2 negatively 
regulates the nuclear localization, and 
hence transcriptional activity, of SKN-1 in 
intestinal nuclei; amongst the 38 
predicted insulin-like molecules in C. 
elegans, genetic and microarray analyses 
suggest that at least DAF-28, INS-1, and 
INS-7 are likely DAF-2 ligands; genetic 
mosaic and tissue-specific promoter 
studies indicate that daf-2 can function 
cell nonautonomously and within multiple 
cell types to influence dauer formation 
and adult lifespan, likely by regulating the 
production of secondary endocrine 
signals that coordinate growth and 
longevity throughout the animal; temporal 
analysis of daf-2 function indicates that 
daf-2 regulates lifespan, reproduction, 
and diapause independently, at distinct 
times during the animal's life cycle. 
13. daf-18 Encodes a lipid phosphatase homologous 
to the human PTEN tumor suppressor 
(OMIM:601728, mutated in Cowden 
disease and several cancers); DAF-18 
negatively regulates insulin-like signaling 
mediated by DAF-2/IR and AGE-1/PI3K 
and thus plays a role in metabolism, 
development, and longevity; based on 
sequence and genetic analysis, DAF-18 
is predicted to dephosphorylate AGE-1-
generated PIP3 in order to limit activation 
of the downstream AKT-1 and AKT-2 
kinases that negatively regulate DAF-16. 
14. daf-16 Encodes the sole C. elegans forkhead 
box O (FOXO) homologue; DAF-16 
functions as a transcription factor that 
8 
 
acts in the insulin/IGF-1-mediated 
signaling (IIS) pathway that regulates 
dauer formation, longevity, fat 
metabolism, stress response, and innate 
immunity. 
15. DAF 7/ TGF-ß Encodes a member of the transforming 
growth factor beta superfamily; in C. 
elegans, DAF-7 functions as part of a 
signaling pathway that interprets 
environmental conditions to regulate 
energy-balance pathways that affect 
dauer larval formation, fat metabolism, 
egg laying, pathogen avoidance behavior, 
and feeding behavior. 
16. DAF-3  Encodes a co-SMAD protein that is most 
closely related to Drosophila Medea and 
the vertebrate Smad4 proteins; DAF-3 
functions as a transcriptional regulator 
that is required for formation of the 
alternative dauer larval stage as well as 
for regulation of pharyngeal gene 
expression during non-dauer 
development; DAF-3 activity is 
antagonized by signaling through the 
DAF-7/TGF-beta pathway which 
promotes reproductive growth. 
17. AGE-1/ PI3K Encodes the C. elegans ortholog of the 
phosphoinositide 3-kinase (PI3K) lying 
downstream of the DAF-2/insulin receptor 
and upstream of both the PDK-1 and 
AKT-1/AKT-2 kinases and the DAF-16 
forkhead type transcription factor, whose 
negative regulation is the key output of 
the insulin signaling pathway; in 
accordance with its role in insulin 
signaling, AGE-1 activity is required for 
regulation of metabolism, life span, dauer 
formation, stress resistance, salt 
chemotaxis learning, fertility, and 
embryonic development. 
18. AKT-1 Encodes an ortholog of the 
serine/threonine kinase Akt/PKB; akt-1 
genetically interacts with the insulin 
signaling pathway and functions to 
regulate such processes as dauer larval 
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development and salt chemotaxis 
learning. 
19. tub-1 Encodes a TUBBY homolog that affects 
fat storage across species including C. 
elegans. 
20. FAT-5 Encodes a delta-9 fatty acid desaturase 
that is predicted to be mitochondrial. 
21. FAT-6 Encodes an Acyl-CoA desaturase (also 
known as delta-9 fatty acid desaturase). 
22. pod-2 Encodes an acetyl-CoA carboxylase; by 
sequence similarity, POD-2 is predicted 
to catalyze the first step in de novo fatty 
acid biosynthesis. 
23. sbp-1 Encodes a basic helix-loop-helix (bHLH) 
transcription factor homologous to the 
mammalian Sterol Regulatory Element 
Binding Proteins (SREBPs, 
OMIM:184756, overexpression of nuclear 
form of SREBP-1c is associated with 
insulin resistance and features of 
congenital generalized lipodystrophy); in 
C. elegans, SBP-1 activity is required for 
normal lipid metabolism and wild-type 
levels of lipogenic enzyme expression, as 
well as for embryonic and larval 
development; in addition, sbp-1 is 
required for mediating the lipid 
accumulation and increased body 
width/length ratio that occurs in response 
to oxygen deprivation; sbp-1 expression 
is detected in the intestine, the major site 
of fat storage, from early embryogenesis 
through adulthood and also in the amphid 
neurons. 
24. FAT-2 Encodes a delta-12 fatty acyl desaturase 
that increases membrane fluidity when 
expressed in yeast, and that may protect 
against cold stress; FAT-2's substrate is 
unknown, but may be acyl-CoA; FAT-2 is 
required in vivo for normal levels of C18 
or C20 polyunsaturated fatty acids 
(PUFAs). 
25. FAT-1 Encodes an omega-3 fatty acyl 
desaturase that acts on substrates of 16-
20 carbons with a preference for omega-6 
fatty acids; FAT-1 dehydrogenates its 
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substrates 3 carbons from the methyl 
terminus; FAT-1 is required in vivo for n3 
polyunsaturated fatty acid (PUFA) 
synthesis. 
26. FAT-3 Encodes a delta-6 fatty acid desaturase 
('linoleoyl-CoA desaturase') containing an 
N-terminal cytochrome b5 domain that is 
orthologous to the vertebrate fatty acid 
desaturases (FADS). 
27. ELO-5 Gene encodes a paralog of elo-1 and elo-
2, each of which encodes a 
polyunsaturated fatty acid (PUFA) 
elongase; ELO-5 is required for normally 
rapid growth and for normal fatty acid 
composition. 
28. ELO-1 Encodes a component of C-18 
polyunsaturated fatty acid (PUFA) 
elongase that is required for normal 
elongation of n-6 and n-3 20-carbon 
PUFA in vivo; ELO-1 is a condensing 
enzyme that elongates n-6 and n-7 (and, 
with less efficiency, n-3) series C18 
PUFAs. 
29. ELO-2 Encodes a palmitic acid elongase, 
homologous to polyunsaturated fatty acid 
(PUFA) elongases such as ELO-1, that is 
required for normally rapid growth, 
normally large body size, fertility, and for 
the quantitative regulation of the ultradian 
defecation rhythm; the joint action of 
ELO-2 with ELO-1 is strongly required for 
20-carbon PUFA production and for 
general viability. 
30. ELO-6 Encodes a paralog of elo-1 and elo-2, 
each of which encodes a polyunsaturated 
fatty acid (PUFA) elongase; ELO-6 may 
be required for a normally high growth 
rate. 
 
CHAPTER 2: MATERIALS AND METHODS 
 
2.1- Research Design and Methods 
 
The worms were grown on Nematode Growth Medium (NGM), because this is the 
standard medium for the worms. The worms were grown on 6cm petri plates. Wild-Type, 
N2, C.  elegans were used. For treatment with sodium benzoate, 80µL sodium benzoate 
of various concentrations were added to the top of the growth medium for the worms to 
consume. These concentrations were of 0.05%, 0.1%, and 0.5%. These percentages 
were chosen based on the FDA standard limit of 0.1%, with 0.05% reflecting a lower test 
dosage and 0.5% reflecting a higher test percentage [3]. A positive control of 0.5% 
glucose was also used because glucose at this level has been shown in previous studies 
to increase fat storage in C. elegans [7]. A negative control plate containing only OP50 
was also used. Before the test worms are plated age- synchronization will be performed 
to ensure all worms are in the same developmental stage. The worms will be fed OP50, 
a strain of E. Coli that is not harmful, which is a standard food source for C. elegans. To 
stain the fat stores of the worms Nile Red was used. This method was chosen because it 
is a common fat staining method for C. elegans. A ZEISS Z1 AxioObserver fluorescent 
microscope with be used to examine fat deposition.  The expression profiles of 30 genes 
of interest will be examined using qRT-PCR.  
2.2- Synchronization 
 
The worms were washed with 7mL of a standard M9 solution from the plate and added 
to a 15 mL centrifuge tube. The worms were then centrifuged at 2000rpm for 2 minutes. 
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The supernatant was removed, and the worms were suspended again in 7mL of M9. The 
worms were then centrifuged again, the supernatant was removed, and 7 mL of M9 was 
added to the tube. The worms were then centrifuged again. The supernatant was 
removed and a solution containing 1400 µL bleach, 700 µL sodium hydroxide, and 5mL 
water was added to a centrifuge tube containing adult worms and eggs. The tube was 
shaken until the adult worms dissolved, leaving behind only eggs. The eggs were then 
centrifuged, and the bleach solution was removed. The worms were then rinsed with 7mL 
of M9 and centrifuged. The M9 supernatant was removed and fresh M9 is added to the 
tube. More M9 was added to the tube and the washing process was repeated two more 
times. The worms were then placed on a shaker in the incubator at 20°C for 18 hours to 
allow the worms to hatch. Since there is no food source in the tube, the worms all 
remained in the same phase of development, the L1 phase. The worms were then plated 
on treatment plates, or control plates. This process is important to ensure the worms are 
all in the same stage of development.  
 
2.3- Sodium Benzoate Treatments 
 
Wild Type N2 worms, that were grown as previously described, were gathered from NGM 
plates and synchronized, as described previously. Five treatment plates were then 
prepared using 6 cm NGM plates. To prepare the treatment plates 80 µL of 0.05% sodium 
benzoate was added to plate 1, 80 µL of 0.1% sodium benzoate was added to plate, 80 
µL of 0.5% sodium benzoate was added to plate 3, 80 µL of 0.5% glucose was added to 
plate 4 to serve as a positive control, and no sodium benzoate was added to plate 5 to 
serve as a negative control. The plates were allowed to dry and then 80 µL of OP50 was 
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added to each plate and allowed to dry. Then 80 µL of Nile Red dye with a concentration 
of 0.25 µg/mL was added to each of the plates and allowed to dry. After the plates dried, 
the synchronized L1 worms were distributed approximately equally among the 5 prepared 
plates to begin the exposure.  Each treatment plate was replicated three times for a total 
of fifteen plates. Worms were then chosen at random from each plate and mounted on 2 
% agarose slides. The worms were then examined using fluorescence microscopy at 24 
hours exposure, 48 hours exposure, and 72 hours exposure.  Zeiss ZEN Blue Software 
was used to determine the body area, length, and fluorescence intensity for each worm. 
Each worm was manually outlined and measured using the microscope software. After 
the worm is outlined, the software generates the area and fluorescence intensity value of 
the worm automatically. To determine the length of each worm, a line was drawn down 
the center of the worm from its head to its tail. Once the line is drawn the software 
automatically generates the length measurement.  
2.4- Nile Red Staining 
 
Nile Red powder (N-1142 Molecular Probes) was dissolved in acetone at 500 µg/ml, 
diluted in 1X phosphate buffered saline (PBS) and added on top of nematode growth 
media (NGM) plates already seeded with OP50, to a final concentration of 0.25 µg/ml 
[12]. Worms were placed on the treatment plates as starved L1s from the synchronization. 
The staining phenotypes were then assessed at various exposure times including: 24 
hours, 48 hours, and 72 hours using fluorescence microscopy with a ZEISS Z1 
AxioObserver microscope. The worms were mounted on 2% agarose slides and 
photographed. Changes in body fat deposition were examined. 
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2.5- Calculating Total Fluorescence 
 
Using ImageJ© software, total fluorescence can be calculated. Using an Excel 
spreadsheet, image fluorescence can be calculated using measurements obtained 
through ImageJ©.  Once the application is open, the area of interest is selected using the 
drawing tools. From the Analyze menu, set measurements must be selected, and area 
integrated intensity and mean grey value selected should be selected in that menu. The 
area of interest in then measured. After the area of interest is measured, 3 separate 
background areas are also selected and measured. This eliminates any background 
noise. After the measurements are taken they can be inserted into the following formula 
in an Excel Spreadsheet: CTCF = Integrated Density – (Area of selected cell x Mean 
fluorescence of background readings). The CTCF was then standardized based on size. 
The CTCF value was divided by each worm’s size to standardize the measurements.  
 
2.6- Isolation of RNA 
 
RNA was isolated using the following protocol. Worms were collected from 3 control 
plates and 3 0.1% sodium benzoate treatment plates to serve as 3 biological replicates. 
Worms were then frozen at -80°C until RNA extraction was performed. RNA isolation was 
then performed using the following protocol.  400 µL Lysis/ Binding Buffer was added into 
each 2mL centrifuge tube containing worms on ice. Tubes were sonicated for 15-10 
seconds using Ultrasonic Convertor on ice. 40 µL of miRNA Homogenate Additive was 
added to the tissue lysate and mixed well by inverting the tube several times. The mixture 
was left on ice for 10 minutes. 400 µL of Acid-Phenol:Choloform was then added to each 
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tube. The tubes were vortexed for 30-60 seconds to mix. The tubes were centrifuged for 
5 minutes at 10,000 x g at room temperature. The aqueous phase was recovered and 
transferred to a fresh tube. 375 µL of room temperature 100% ethanol was added to the 
aqueous phase and mixed thoroughly. For each sample, a filter cartage was placed into 
a collection tube. The lysate/ethanol mixture was pipetted into the filter cartridge. Up to 
700 µL can be applied at a time. The tubes were centrifuged for 15 seconds at 10,000 x 
g to pass the mixture through the filter. The flow-through was discarded and the process 
was repeated until lysate/ ethanol mixture was through the filter. 700 µL miRNA Wash 
Solution 1 was applied to the filter cartridge and centrifuged for 10 seconds. The flow-
through was discarded and the filter cartridge was replaced. 500 µL Wash solution 2/3 
was applied and the tubes were centrifuged for 10 seconds. The flow-through was 
discarded. This was step was repeated. The filter cartridge was replaced, and the tubes 
were spun for 1 minute to remove residual fluid from the filter. The filter cartridge was 
transferred to a fresh collection tube and 50 µL of pre-heated (95°C) nuclease-free water 
was applied to the center of the filter. The cap was closed, and the tubes were spun for 
30 seconds at 10,000 x g to recover RNA. The RNA sample was gently mixed, and the 
RNA concentration was measured using the Nano-Drop 1000. RNA quality of each tube 
was measured using the NanoDrop ND-1000 Micro-Volume UV-Vis Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE) and based on the absorbance ratios of 
260/280 and 260/230. 
 




After NanoDrop analysis of the RNA samples, RT-PCR was performed using a TaqMan® 
MicroRNA Reverse Transcription Kit. 6 new 0.5 ml microfuge tubes were collected. 
Several calculations were made to determine how much nuclease free water, RNA 
sample, and master mix would be added to each the microfuge tubes. 1 µg of total RNA 
per 15 µL RT reaction was used. This amount is calculated based on the RNA 
concentration. The master mix contained calculated volumes of components provided by 
the kit (RNase inhibitor, 100 mM dNTPs, 10X Reverse Transcription Buffer, Multiscribe™ 
Reverse Transcriptase, and primer mix (not provided in kit)).  After each tube received 
calculated volumes of nuclease-free water, RNA sample, and the master mix, the tubes 
were mixed gently and centrifuged for 10 seconds (200 rpm). The tubes were then 
incubated on ice for 5 minutes and loaded into the thermal cycler for reverse transcription. 
The thermal cycler process includes 30 minutes at 16°C, 30 minutes at 42°C, 5 minutes 
at 85°C, and will hold at 4°C. After RT-PCR, each tube, now containing RT product or 
cDNA, was removed from the thermal cycler and each tube received 80 μl of DNase-free 
water. The tubes were then mixed by vortexing and immediately stored at -20°C until 




Previously made RT-PCR products and purchased SYBR® Green dye were placed on 
ice to thaw. The previous products were further diluted using Nuclease-free water. Using 
6 96-well microplates, following a written template, I loaded each individual well with 7 μL 
RNase DNase-free water, 10 μL SYBR® Green dye, and 1 μL RT-PCR product. I then 
loaded each well with 2 μl of primer solution (1 μl forward and 1 μl reverse) specific to the 
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genes of interest. The gene act-1 was used as a reference gene. For each RT-PCR 
product there were 3 technical replicates. Once the plate was fully loaded it was covered 
and sealed tightly with a film to prevent evaporation of any well samples. The plate was 
then centrifuged to ensure each sample mixture is settled on the bottom of each well. 
Next, the plate was loaded into the qRT-PCR machine to undergo one 10-minute cycle 
at 95°C (enzyme activation), and 45 PCR cycles including 15 seconds at 95°C 
(denaturation of DNA), and 60 seconds at 60°C (DNA annealing and extension). 
2.9- Statistical Analysis 
 
For statistical analysis, the IBM SPSS Statistics 25 software for Windows 7 was used. To 
determine statistical differences between treatment and control groups in area, length, 
intensity mean fluorescence, corrected total cell fluorescence, and gene expression fold 
changes the statistical test analysis of variance (ANOVA) was used. Least significant 
difference (LSD) multiple comparisons were carried out to compare means among 
groups. The significance level for all analysis performed was p <0.05.
 
CHAPTER 3: RESULTS 
3.1- Impact of Sodium Benzoate on Growth 
 
Sodium Benzoate treated one and a half-day old N2 worms had an average area of: 
7832.78 µm2 for the negative control, 7530.15 µm2 for the 0.05% treatment, 6175.70 
µm2 for the 0.1% treatment, 9546.90 µm2 for the 0.5% treatment, and 9537.24 µm2 for 
the 0.05% glucose positive control (Fig 1). There was a significant difference in body 
size when comparing the positive control group to all other treatment groups. The 0.5% 
sodium benzoate treatment group and the 0.5% glucose group (positive control) were 
statistically larger than the control group. The 0.1% sodium benzoate treatment group 
was statistically smaller than the control group and the 0.05% sodium benzoate 





Sodium Benzoate treated one and a half-day old N2 worms had an average length of: 
377.28µm for the negative control, 360.37µm for the 0.05% treatment, 334.14µm for the 
0.1% treatment, 395.17µm for the 0.5% treatment, and 386.20µm for the 0.05% glucose 
positive control (Fig 2). There was not a significant difference in body length when 
comparing the negative control group to the 0.05% sodium benzoate group or the 0.5% 
glucose group. There was also not a statistically significant difference in body length 
Figure 1. Average size following 24 hours of exposure. Different letters denote statistically 
significant differences. Error Bars indicate the standard error of 3 replicate plates. Ncontrol =14, N0.05% 



































when comparing the negative control group to the 0.05% sodium benzoate treatment 
group. However, the 0.05% treatment group was significantly smaller than both the 
0.5% sodium benzoate group and the 0.5% glucose group. The 0.1% sodium benzoate 




Sodium Benzoate treated two and a half-day old N2 worms had an average area of: 



































Average Length in µm After 24 Hours Exposure 
to Sodium Benzoate
Figure 2. Average length following 24 hours of exposure. Different letters denote statistically 
significant differences. Error Bars indicate the standard error of 3 replicate plates. Ncontrol =14, 




28124.0µm2 for the 0.1% treatment, 27284.0µm2 for the 0.5% treatment, and 
28535.80µm2 for the 0.05% glucose positive control (Fig 3). There was a significant 
increase in body size in the 0.1% sodium benzoate group, the 0.5% sodium benzoate 
group, and the 0.5% glucose group, when compared the control. There was not a 
statistical difference in body size between the control group and the 0.05% sodium 







































Average Area in µm² After 48 Hours Exposure
Figure 3. Average body area of N2 worms 48 hours after dosing. Different letters denote 
statistically significant differences. Error Bars indicate the standard error of 3 replicate plates. 
Ncontrol =35, N0.05% Sodium Benzoate =33, N0.1% Sodium Benzoate =31, N0.5% Sodium Benzoate =21, and N0.5% 
Glucose =33, p< 0.05. 
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Sodium Benzoate treated two and a half-day old N2 worms had an average length of: 
564.09µm for the negative control, 605.36µm for the 0.05% treatment, 692.98µm for the 
0.1% treatment, 658.54µm for the 0.5% treatment, and 651.70µm for the 0.05% glucose 
positive control (Fig 4). There was a significant increase in length across all treatment 
groups when compared to the negative control group. The 0.1% sodium benzoate 
treatment group, 0.5% sodium benzoate treatment group, and the 0.5% glucose group 








































Average Length in µm After 48 Hour Exposure
Figure 4. Average body length of N2 worms 48 hours after dosing. Different letters denote 
statistically significant differences. Error Bars indicate the standard error of 3 replicate plates. 
Ncontrol =35, N0.05% Sodium Benzoate =33, N0.1% Sodium Benzoate =31, N0.5% Sodium Benzoate =21, and N0.5% Glucose 
=33, p< 0.05. 
23 
 
Sodium Benzoate treated three and a half-day old N2 worms had an average area of: 
44645.34µm2 for the negative control, 46009.49µm2 for the 0.05% treatment, 
53475.04µm2 for the 0.1% treatment, 74953.68µm2 for the 0.5% treatment, and 
57614.24µm2 for the 0.05% glucose positive control (Fig 5). The 0.5% sodium benzoate 
treatment group was significantly larger than all other treatment groups. The 0.5% 
glucose treatment group was significantly larger than both the control and 0.05% 
sodium benzoate treatment groups, and there was not a statistical difference compared 
to the 0.1% sodium benzoate group. The control group was not statistically different in 
size when compared to the 0.05% sodium benzoate group or the 01% sodium benzoate 













Sodium Benzoate treated three and a half-day old N2 worms had an average length of: 
785.39µm for the negative control, 816.51µm for the 0.05% treatment, 870.15µm for the 
0.1% treatment, 1042.11µm for the 0.5% treatment, and 890.82µm for the 0.05% 
glucose positive control (Fig 6). There was a significant difference in body length in the 






































72 Hours Exposure Average Area in µm² 
Figure 5. Average body area of N2 worms 72 hours after dosing. Different letters denote 
statistically significant differences. Error Bars indicate the standard error of 3 replicate plates. 
Ncontrol =20, N0.05% Sodium Benzoate =32, N0.1% Sodium Benzoate =21, N0.5% Sodium Benzoate =21, and N0.5% 







Over the period of 72-hour exposure, the 0.5% sodium benzoate group was much larger 
that the negative control group. While they were not statistically larger, all other 

































72 Hour Exposure Average Length in µm
Figure 6. Average body length of N2 worms 72 hours after dosing. Different letters denote 
statistically significant differences. Error Bars indicate the standard error of 3 replicate plates. 
Ncontrol =20, N0.05% Sodium Benzoate =32, N0.1% Sodium Benzoate =21, N0.5% Sodium Benzoate =21, and N0.5% Glucose 








The average body length of the worms was similar across all treatment groups at 24 
hours with the 0.05% treatment group and the 0.1% treatment group being slightly 
smaller. At 48 hours the control and 0.05% treatment group had similar lengths, 
however the 0.1% treatment group, 0.5% treatment group, and the 0.5% glucose 
groups were all longer. At the end of 72 hours the 0.5% treatment group was much 

































Average Area in µm² Over Time
24 Hours 48 Hours 72 Hours







3.2- Impact of Sodium Benzoate on Fat Deposition Based on Fluorescence 
 
Sodium benzoate treated worms showed less fluorescence that the control worms after 
24 hours of exposure. Glucose treated worms also demonstrated less fluorescence (Fig 
9).  































Average Length in µm Over Time
24 Hours 48 Hours 72 Hours







       
 
Sodium Benzoate treated one and a half-day old N2 worms had an average Corrected 
Total Cell Fluorescence (CTCF) of of: 12.33 for the negative control, 7.04 for the 0.05% 
treatment, 8.44 for the 0.1% treatment, 8.92 for the 0.5% treatment, and 6.88 for the 
0.05% glucose positive control (Fig 10). All treatment groups had significantly less 
fluorescence than the control group at 24 hours (p<0.05).  
 
d e 
Figure 9. Example of Nile Red dye stained worms at 24 hours exposure. a) Control Worm b) 









Sodium Benzoate treated one and a half-day old N2 worms had an average intensity 
mean fluorescence of: 2962.69 for the negative control, 1709.86 for the 0.05% 
treatment, 1838.41 for the 0.1% treatment, 1838.37 for the 0.5% treatment, and 
1292.16 for the 0.05% glucose positive control (Fig 11). All treatment groups had 
significantly less fluorescence than the control group at 24 hours with the 0.5% glucose 












































Average Standardized CTCF Values at 24 
Hours Exposure
Figure 10. Average Corrected Total Cell Fluorescence of N2 worms 24 hours dosing. 
Different letters denote statistically significant differences. Error Bars indicate the standard 
error of 3 replicate plates. Ncontrol =14, N0.05% Sodium Benzoate =12, N0.1% Sodium Benzoate =18, N0.5% 










Sodium Benzoate worms showed approximately the same fluorescence at 48 hours 
exposure, except the 0.1 % treatment group which showed less fluorescence (Fig 12) . 
Glucose treated worms also showed similar fluorescence to control worms at 48 hours.  





































Average Intensity Mean of Fluoresence After 
24 Hours Exposure to Sodium Benzoate
a 
Figure 11. Average Fluorescence based on intensity mean of N2 worms 24 hours 
dosing. Different letters denote statistically significant differences. Error Bars indicate the 
standard error of 3 replicate plates. Ncontrol =14, N0.05% Sodium Benzoate =12, N0.1% Sodium Benzoate =18, 





   
 
Sodium Benzoate treated two and a half-day old N2 worms had an average Corrected 
Total Cell Fluorescence (CTCF) of: 2.92 for the negative control, 2.33 for the 0.05% 
treatment, 1.93 for the 0.1% treatment, 2.68 for the 0.5% treatment, and 2.51 for the 
0.05% glucose positive control (Fig 13). When comparing the treatment groups to the 
control groups, only the 0.1% treatment group was statistically different. Total 
Fluorescence was not impacted by treatment after 48 hours of exposure in most groups. 
Fluorescence decreased in the 0.1% treatment group (P<0.05).  
d e 
Figure 12. Example of Nile Red dye stained worms at 48 hours exposure. a) Control Worm b) 








Sodium Benzoate treated two and a half-day old N2 worms had an average intensity 
mean fluorescence of: 653.53 for the negative control, 568.66 for the 0.05% treatment, 
490.29 for the 0.1% treatment, 633.30 for the 0.5% treatment, and 549.18 for the 0.05% 
glucose positive control (Fig 14). When comparing the treatment groups to the control 
groups, only the 0.1% treatment group was statistically different. Intensity mean 
fluorescence was not impacted by treatment after 48 hours of exposure in most groups. 










































Average Standardized CTCF Values at 48 
Hours Exposure
Figure 13. Average Corrected Total Cell Fluorescence of N2 worms after 48 hours of 
dosing. Different letters denote statistically significant differences. Error Bars indicate the 
standard error of 3 replicate plates. Ncontrol =35, N0.05% Sodium Benzoate =33, N0.1% Sodium Benzoate =31, 









Sodium Benzoate treated worms in the 0.05% group, and the glucose treated group, 
showed the most fluorescence at 72 hours. The control group showed the least 
fluorescence at 72 hours.  







































Average Intensity Mean Fluoresence After 48 
Hours
Figure 14. Average Corrected Total Cell Fluorescence of N2 worms after 48 hours of 
dosing. Different letters denote statistically significant differences. Error Bars indicate the 
standard error of 3 replicate plates. Ncontrol =35, N0.05% Sodium Benzoate =33, N0.1% Sodium Benzoate 
=31, N0.5% Sodium Benzoate =21, and N0.5% Glucose =33, p< 0.05. 
 
a b c 
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Sodium Benzoate treated three and a half-day old N2 worms had an average Corrected 
Total Cell Fluorescence (CTCF) of: 9.08 for the negative control, 14.79 for the 0.05% 
treatment, 11.19 for the 0.1% treatment, 12.55 for the 0.5% treatment, and 15.3 for the 
0.05% glucose positive control (Fig 16). When comparing the treatment groups to the 
control group, the 0.05% sodium benzoate and 0.5% glucose treatment groups were 
statistically more fluorescent than the control group. However, despite not being 
statistically more fluorescent, all treatment groups were more fluorescent that the 





Figure 15. Example of Nile Red dye stained worms at 72 hours exposure. a) Control Worm 











Sodium Benzoate treated three and a half-day old N2 worms had an average intensity 
mean fluorescence of: 9.08 for the negative control, 14.79 for the 0.05% treatment, 
11.19 for the 0.1% treatment, 12.55 for the 0.5% treatment, and 15.3 for the 0.05% 
glucose positive control (Fig 17). When comparing the treatment groups to the control 
group, the 0.05% sodium benzoate and 0.5% glucose treatment groups were 



















































Average Standardized CTCF Values at 72 
Hours Exposure
Figure 16. Average Corrected Total Cell Fluorescence of N2 worms after 72 hours of 
dosing. Different letters denote statistically significant differences. Error Bars indicate the 
standard error of 3 replicate plates. Ncontrol =20, N0.05% Sodium Benzoate =32, N0.1% Sodium Benzoate 
=21, N0.5% Sodium Benzoate =21, and N0.5% Glucose =18, p< 0.05. 
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statistically more fluorescent, all treatment groups were more fluorescent that the 










The average corrected total cell fluorescence decreased from 24 hours to 72 hours in 







































72 Hour Exposure Average Intensity Mean
Figure 17. Average Intensity Mean fluorescence of N2 worms after 72 hours of 
dosing. Different letters denote statistically significant differences. Error Bars indicate the 
standard error of 3 replicate plates. Ncontrol =20, N0.05% Sodium Benzoate =32, N0.1% Sodium Benzoate 
=21, N0.5% Sodium Benzoate =21, and N0.5% Glucose =18, p< 0.05.  
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The average intensity mean fluorescence decreased from 24 hours to 72 hours in the 
control group. In all other treatment groups, the fluorescence increased from 24 hours to 





























Standardized CTCF Averages Over Time
24 Hours 48 Hours 72 Hours








3.3- Gene Expression Analysis 
 
Gene expression analysis using qRT-PCR revealed one significant fold change in the 
selected nuclear hormone genes of interest. Table 2 summarizes the fold changes in the 
nuclear hormone receptor genes of interest. NHR-50 had a significant down-regulated 
































Average Intensity Mean Over Time
24 Hours 48 Hours 72 Hours
Figure 19. Standardized corrected total cell fluorescence over the course of the 72-hour 
exposure period. 
Table 2.  Summary of fold changes in nuclear hormone receptor genes: Fold changes after 24 
hours exposure. Asterisk (*) indicates a significant fold change, p< 0.05. 
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Gene Average Fold Change Direction of Fold Change 
NHR-170 8.624760794 UP 
NHR-206 0.241247257 Down 
NHR21 1.197954682 Up 
NHR-64 0.678496003 Down 
NHR-8 0.587936262 Down 
NHR-50 0.347675237 * Down 
NHR-18 0.775429635 Down 
NHR-120 0.573403785 Down 
NHR-49 0.494181265 Down 
NHR-162 0.058721574 Down 





Gene expression analysis using qRT-PCR revealed no significant fold changes in the 
genes of interest in the insulin signaling pathway (Fig 21). Table 3 summarizes the fold 













Nuclear Hormone Receptor Genes of Interest
Average Fold Change in Selected Nuclear 
Hormone Receptor Genes
Figure 20. Fold changes in nuclear hormone receptor genes. Visual representation of fold 
changes discovered using gene expression analysis in selected nuclear hormone receptor genes 
after 24 hours exposure. Error bars represent standard error of the 3 biological replicates. Asterisk (*) 
indicates a significant fold change, p< 0.05. 
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Gene Average Fold Change Direction of Fold Change 
DAF-2 1.064834256 UP 
DAF-18 0.440961111 Down 
DAF-16 15.32656215 Up 
DAF-7 0.589453989 Down 
DAF-3 0.808632821 Down 
AGE-1 46.38538251 Up 







Gene expression analysis using qRT-PCR revealed two significant fold changes in the 












Genes of Interest in the Insulin Signaling Pathway
Average Fold Change of Genes In the Insulin 
Signaling Pathway
Table 3.  Summary of fold changes in insulin signaling pathway genes:  Fold changes after 24 
hours exposure. An asterisk (*) indicates a significant fold change, p< 0.05. 
 
Figure 21. Fold changes in insulin signaling genes. Visual representation of fold changes 
discovered using gene expression analysis in selected insulin signaling pathway genes after 24 hours 
exposure. Error bars represent standard error of the 3 biological replicates. An asterisk (*) indicates a 
significant fold change, p< 0.05. 
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the insulin signaling pathway genes of interest. The genes FAT-1 and ELO-5 both had 
significant fold changes (Fig 22).  
 
Gene Average Fold Change Direction of Fold Change 
TUB-1 0.732861368 Down 
FAT-5 1.001287772 Up 
FAT-6 0.64524944 Down 
Pod-2 2.02272629 Up 
Sbp-1 1.002935543 Up 
Fat-2 1.242499745 Up 
FAT-1 0.072001073 ** Down 
FAT-3 0.345381382 Down 
ELO-5 0.747112981 * Down  
ELO-1 1.476702175 Up 
ELO-2 2.02272629 Up 
ELO-6 0.372347953 Down 
 
 
Table 4. Summary of fold changes in fatty acid synthesis genes:  Fold changes after 24 hours 
exposure. An asterisk (*) indicates a significant fold change of p< 0.05 and a double asterisk (**) 

















Genes of Interest Involved in Fatty Acid Synthesis
Average Fold Change of Genes Involved in Fatty 
Acid Synthesis
Figure 22. Fold changes in fatty acid synthesis genes. Visual representation of fold changes 
discovered using gene expression analysis in selected genes involved in fatty acid synthesis after 24 
hours exposure. Error bars represent standard error of the 3 biological replicates. An asterisk (*) 
indicates a significant fold change of p< 0.05 and a double asterisk indicates a significant fold change 
of p< 0.01.  
 
CHAPTER 4: DISCUSSION 
This research demonstrates that sodium benzoate greatly effects the growth of 
C. elegans at various concentrations. After only 24 hours of exposure, the highest 
treatment group was significantly larger in size when compared to the negative control 
group. After 48 hours of exposure, both the middle and high treatment groups were 
significantly larger in size, and longer, than the negative control group. Lastly, after 72 
hours of exposure, the highest treatment group was significantly larger in size, and 
longer, than both the negative and positive control groups. This evidence shows that 
sodium benzoate exposure has a large impact on growth in C. elegans. The mechanism 
behind this altered growth was not discovered during this research. Further research 
should be conducted to examine the effect of sodium benzoate on growth over time to 
discover a mechanism this effect.  
The results for the effect on fat deposition were somewhat inconclusive. After 24 
hours of exposure, fluorescence decreased across all treatment groups, when 
compared to the control group.  After 48 hours of exposure, the fluorescence was much 
lower in all test groups. The reason for this major decrease in fluorescence across all 
groups was not discovered. For this reason, this experiment should be repeated in the 
future to make sure these results can be replicated.   Lastly, after 72 hours of exposure 
fluorescence increased in all treatment groups, with a significant increase in the lowest 
treatment group. This increase in fluorescence suggests that sodium benzoate is 
increasing fat deposition in C. elegans, based on previous studies using Nile Red to 
stain major fat storage in the organism [1].  However, after this research was conducted, 
a study was discovered that demonstrated that Nile Red may not actually stain the 
44 
 
major fat storage vesicles in C. elegans [12]. This study showed that Nile Red stained 
lysosome related organelles and that C. elegans major fat stores are contained in 
independent specialized neutral lipid-containing vesicles [12]. Their study indicated that 
the lysosome related organelles may play an important role in metabolism and lipid 
degradation [12]. The study also noted increased Nile Red staining of lysosomes may 
be a predictor of decreased resistance to stress, and a shortened life span [12].  Based 
on these previous findings, my research suggests that sodium benzoate may be 
decreasing the lifespan of C. elegans.  If the Nile Red stained lysosomes in my study, 
then the increased fluorescence could indicate a reduced resistance to stress, and to 
probability of a shorter lifespan. This could also explain the overgrowth in the treatment 
groups in this study. However, in the previous study they also state that under certain 
conditions, Nile Red dye could stain neutral lipids as well [12]. Due to the findings in the 
previous study, a conclusion about the effects of sodium benzoate on fat deposition 
cannot be drawn. Further research must be performed. The previous study validated the 
use of the fat staining dye Oil Red O to stain neutral lipid stores in C. elegans [12]. In 
the future, Oil Red O should be used along with Nile Red so the results from the two 
stains can be compared. Since Oil Red O was shown to stain neutral lipids, it should 
demonstrate the effects on fat deposition in C. elegans. However, it should be noted 
that the procedure involved in fixative Oil Red O staining is very detailed and lengthy. It 
could be challenging to use that staining method in this specific experiment.  
Lastly, the gene expression analysis revealed a significant decrease in the 
expression of three genes of interest, elo-5, fat-1, and nhr-50. The gene elo-5 encodes 
a polyunsaturated fatty acid elongase, and elo-5 is required for normal fatty acid 
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composition [5]. The significant decrease in the gene expression shows that the C. 
elegans demonstrates that after 24 hours exposure, fat composition is affected in the 
middle treatment group. This finding matches the fluorescence data for the middle 
treatment group at 24 hours, because fluorescence is lower compared to the control 
group at this time. This suggest less lipids are being produced overall. The gene fat-1 is 
required in vivo for n3 polyunsaturated fatty acid synthesis [5] . The significant decrease 
in gene expression for this gene also demonstrates that fatty acid synthesis is being 
affect at 24 hours exposure in the middle treatment group. This matches with the data 
from elo-5, as well as, the fluorescence data. The gene nhr-50 is still greatly 
understudied. However, gene expression was shown to increase in response to 
starvation and decrease in response to satiety [9]. The significant decrease in the 
expression of this gene demonstrates that after 24 hours of exposure the worms in the 
middle treatment group were satiated, based on the previous findings. However, it 
should be noted that only one treatment group underwent gene expression analysis in 
this study, and only at one time point. In the future, all treatment groups should be 
analyzed at all time points. The 72-hour time point appears to be the most significant 
timepoint based on the data in this research. Sodium benzoate’s effects on C. elegans 
increase over time. This increase demonstrates that long term exposure has the 
greatest effect on the organism
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